Exclusive

Publication

Byline

Location

Japan's Otsuka and Towa form strategic partnership in pharmaceutical manufacturing

Singapore, Jan. 27 -- Japan-based companies Otsuka Pharmaceutical Co. and Towa Pharmaceutical Co. have entered into an agreement to establish a strategic collaborative framework in pharmaceutical manu... Read More


MS Pharma Group signs exclusive biosimilars collaboration agreement with Hetero

Singapore, Jan. 27 -- MS Pharma Group, a leading regional pharmaceutical company in the Middle East and North Africa (MENA) region, has signed a strategic partnership agreement with Hetero Group, a gl... Read More


Emagene Life Academy launches in Malaysia to advance functional medicine education

Singapore, Jan. 27 -- Emagene Life, a leading functional medicine and longevity practice in Malaysia, has officially launched the Emagene Life Academy, marking a major milestone in the advancement of ... Read More


SK bioscience, MSD, and Hilleman Labs advance Zaire ebolavirus vaccine development

Singapore, Jan. 23 -- South Korea-based SK bioscience has announced that it is advancing the development of a Zaire ebolavirus vaccine under a new collaboration supported by Norway's Coalition for Epi... Read More


Japan's Daiichi Sankyo unveils new Toronto headquarters to accelerate investment and innovation in oncology

Singapore, Jan. 23 -- Japan-based pharmaceutical firm Daiichi Sankyo has further established its presence in Canada with the official opening of its permanent headquarters in Toronto, including additi... Read More


Sisram Medical partners with Sinmait Medical Technology to build manufacturing hub in China

Singapore, Jan. 23 -- Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, has announced that its wholly-owned subsidiary, Sisra... Read More


First fibrotic disease drug of Singapore advances into Phase II clinical evaluation

Singapore, Jan. 21 -- Duke-NUS Medical School in Singapore has noted theannouncement by Boehringer Ingelheimof a Phase IIa clinical study evaluating BI 765423, a first-in-class IL-11 inhibitor for idi... Read More


AstraZeneca buys remaining China rights to GPC3 armored CAR-T therapy from AbelZeta Pharma for $630 M

Singapore, Jan. 21 -- US-based AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic pr... Read More


Pacira partners with LG Chem to make EXPAREL(R) available in select APAC markets

Singapore, Jan. 21 -- US-based Pacira BioSciences, Inc. has entered into an agreement with South Korea's LG Chem designed to expand access to opioid-sparing postsurgical pain control for patients in s... Read More


GSK and Shionogi agree to replace Pfizer's stake in ViiV Healthcare

Singapore, Jan. 21 -- GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK-based ViiV Healthcare Limited, currently held by Pfizer to be... Read More